Emyria (ASX:EMD) Additional Paid-In Capital : A$0.00 Mil(As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Emyria Additional Paid-In Capital?

Emyria Additional Paid-In Capital Historical Data

The historical data trend for Emyria's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Emyria Additional Paid-In Capital Chart

Emyria Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

Additional Paid-In Capital

Emyria Semi-Annual Data
	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial			-	-	-	-	-

Emyria Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Emyria Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Emyria's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Emyria (ASX:EMD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Emyria Ltd (ASX:EMD) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

D2 661 Newcastle Street, PO Box 1442, Leederville, WA, AUS, 6007

Website

https://www.emeraldclinics.com.au

Emyria Ltd operates a network of specialist medical clinics and uses purpose-built software and technology to gather clinical data from consenting patients. It operates in one segment of research and development.